Skip to main content

New Products

  • Teva introduces generic bronchospasm drug

    NORTH WALES, Pa. — Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

    Teva announced the introduction of levalbuterol inhalation solution. The product is a generic version of Sunovion's Xopenex and is available in the 0.31 mg, 0.63 mg and 1.25 mg strengths.

    Various versions of the drug had sales of $438.8 million in 2012, according to IMS Health.

  • Zak's GoPak makes packing healthy lunches a breeze

    SPOKANE, Wash. — Zak Designs has announced a new GoPak container designed to make packing lunches easy and without the worry of messy spills.

  • Life is good, J.M. Smucker announce premium coffee product

    BOSTON & ORRVILLE, Ohio — A collaboration between Life is good Co. and J.M. Smucker Co. will bring a line of coffee products to retail shelves throughout North America.

  • PharmaSmart deploys kiosks in all Kinney Drugs stores

    ROCHESTER, N.Y. — PharmaSmart International's blood-pressure screening program is in use in all the stores of a regional retail pharmacy chain in the Northeast.

    PharmaSmart said it had deployed the peer-reviewed and clinically validated program at Kinney Drugs, which operates 97 stores in upstate New York and Vermont.

  • Planters Peanuts launches energy snack mix

    NEW YORK — Planters Peanuts has launched a new snack mix with the aim to provide a sustaining boost of energy.

    New Planters NUT-rition Sustaining Energy Mix is designed to provide wholesome fuel and is a good source of protein, fiber and four vitamins and minerals, according to the company.

    Planters NUT-rition is available in three varieties:

  • Aurobindo receives FDA approval for hypertension, antibiotic drugs

    HYDERABAD — The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.

    The company announced Tuesday the approval of quinapril tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths. The drug is a generic version of Pfizer's Accupril and is used to treat high blood pressure. Various versions of the drug had sales of about $49 million during the 12-month period ending in September, according to IMS Health.

  • FDA approves anticoagulant-reversal product

    SILVER SPRING, Md. — The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

    The FDA announced the approval of CSL Behring's Kcentra (prothrombin complex concentrate [human]) for the urgent reversal of vitamin K antagonist, or VKA drugs such as warfarin.

  • Drug for rare, fatal genetic disorder receives FDA approval

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.

X
This ad will auto-close in 10 seconds